Given the role of Hsp90 in promoting cancer cell migration and invasion, a critical contributor to metastatic progression, it is reasonable to hypothesise that client proteins of Hsp90 may be coupled with degradation and remodelling of the extracellular matrix (ECM). This evidence concerns the gene HSP90AB1 and cancer.